BACKGROUND: Human ether-à-go-go-related gene (hERG) potassium-channel block represents a harmful side effect of drug therapy that may cause torsade de pointes (TdP). Analysis of ventricular repolarization through electrocardiographic T-wave features represents a noninvasive way to accurately evaluate the TdP risk in drug-safety studies. This study proposes an artificial neural network (ANN) for noninvasive electrocardiography-based classification of the hERG potassium-channel block. METHODS: The data were taken from the "ECG Effects of Ranolazine, Dofetilide, Verapamil, and Quinidine in Healthy Subjects" Physionet database; they consisted of median vector magnitude (VM) beats of 22 healthy subjects receiving a single 500 μg dose of dofetilide. Fourteen VM beats were considered for each subject, relative to time-points ranging from 0.5 hr before to 14.0 hr after dofetilide administration. For each VM, changes in two indexes accounting for the early and the late phases of repolarization, ΔERD30% and ΔTS /A , respectively, were computed as difference between values at each postdose time-point and the predose time-point. Thus, the dataset contained 286 ΔERD30% -ΔTS /A pairs, partitioned into training, validation, and test sets (114, 29, and 143 pairs, respectively) and used as inputs of a two-layer feedforward ANN with two target classes: high block (HB) and low block (LB). Optimal ANN (OANN) was identified using the training and validation sets and tested on the test set. RESULTS: Test set area under the receiver operating characteristic was 0.91; sensitivity, specificity, accuracy, and precision were 0.93, 0.83, 0.92, and 0.96, respectively. CONCLUSION: OANN represents a reliable tool for noninvasive assessment of the hERG potassium-channel block.
BACKGROUND:Human ether-à-go-go-related gene (hERG) potassium-channel block represents a harmful side effect of drug therapy that may cause torsade de pointes (TdP). Analysis of ventricular repolarization through electrocardiographic T-wave features represents a noninvasive way to accurately evaluate the TdP risk in drug-safety studies. This study proposes an artificial neural network (ANN) for noninvasive electrocardiography-based classification of the hERGpotassium-channel block. METHODS: The data were taken from the "ECG Effects of Ranolazine, Dofetilide, Verapamil, and Quinidine in Healthy Subjects" Physionet database; they consisted of median vector magnitude (VM) beats of 22 healthy subjects receiving a single 500 μg dose of dofetilide. Fourteen VM beats were considered for each subject, relative to time-points ranging from 0.5 hr before to 14.0 hr after dofetilide administration. For each VM, changes in two indexes accounting for the early and the late phases of repolarization, ΔERD30% and ΔTS /A , respectively, were computed as difference between values at each postdose time-point and the predose time-point. Thus, the dataset contained 286 ΔERD30% -ΔTS /A pairs, partitioned into training, validation, and test sets (114, 29, and 143 pairs, respectively) and used as inputs of a two-layer feedforward ANN with two target classes: high block (HB) and low block (LB). Optimal ANN (OANN) was identified using the training and validation sets and tested on the test set. RESULTS: Test set area under the receiver operating characteristic was 0.91; sensitivity, specificity, accuracy, and precision were 0.93, 0.83, 0.92, and 0.96, respectively. CONCLUSION: OANN represents a reliable tool for noninvasive assessment of the hERGpotassium-channel block.
Authors: A L Goldberger; L A Amaral; L Glass; J M Hausdorff; P C Ivanov; R G Mark; J E Mietus; G B Moody; C K Peng; H E Stanley Journal: Circulation Date: 2000-06-13 Impact factor: 29.690
Authors: Deborah B Diercks; George M Shumaik; Richard A Harrigan; William J Brady; Theodore C Chan Journal: J Emerg Med Date: 2004-08 Impact factor: 1.484
Authors: JoEllyn M Abraham; Walid I Saliba; Carolyn Vekstein; David Lawrence; Mandeep Bhargava; Mohamed Bassiouny; David Janiszewski; Bruce Lindsay; Michael Militello; Steven E Nissen; Stacy Poe; Christine Tanaka-Esposito; Kathy Wolski; Bruce L Wilkoff Journal: Circ Arrhythm Electrophysiol Date: 2015-06-10
Authors: L Johannesen; J Vicente; J W Mason; C Sanabria; K Waite-Labott; M Hong; P Guo; J Lin; J S Sørensen; L Galeotti; J Florian; M Ugander; N Stockbridge; D G Strauss Journal: Clin Pharmacol Ther Date: 2014-07-23 Impact factor: 6.875
Authors: L Johannesen; J Vicente; R A Gray; L Galeotti; Z Loring; C E Garnett; J Florian; M Ugander; N Stockbridge; D G Strauss Journal: Clin Pharmacol Ther Date: 2013-12-12 Impact factor: 6.875
Authors: Jose Vicente; Lars Johannesen; Jay W Mason; William J Crumb; Esther Pueyo; Norman Stockbridge; David G Strauss Journal: J Am Heart Assoc Date: 2015-04-13 Impact factor: 5.501